Asthma drug developer raises $17 million
Nov 19, 2009 Make Money Online
By Martha Sanchez-Avila
SAN FRANCISCO (Private Equity Week) – Last week asthma drug developer Altair Therapeutics raised $17 million in a Series A funding round that was led by Domain Associates and capped a two-year startup financing period.
Other investors in the round include AgeChem Venture Fund, Thomas McNerney & Partners, Forward Ventures and Isis Pharmaceuticals. Read the rest of this entry »
Tags: AgeChem Venture Fund, Altair Therapeutics, Centers for Disease Control and Prevention, CEO Joel Martin, Domain Associates, Forward Ventures, Forward Ventures and Isis Pharmaceuticals, Pharmaceuticals, Therapeutics, Thomas McNerney & Partners
